Literature DB >> 23229409

Consumption of a high β-glucan barley flour improves glucose control and fatty liver and increases muscle acylcarnitines in the Zucker diabetic fatty rat.

David A Brockman1, Xiaoli Chen, Daniel D Gallaher.   

Abstract

PURPOSE: The soluble fiber β-glucan, a natural component of barley, has been shown to lower the postprandial glucose response and is thought to improve insulin resistance.
METHODS: This study examined the effect of chronic consumption of the high β-glucan barley flour on glucose control, liver lipids and markers of muscle fatty acid oxidation in the Zucker diabetic fatty (ZDF) rat. Two groups of ZDF rats were fed diets containing either 6% β-glucan in the form of barley flour or cellulose as a control for 6 weeks. A group of Zucker lean rats served as a negative control.
RESULTS: The barley flour group had an increased small intestinal contents viscosity compared to the obese control group. After 6 weeks, the barley flour group had reduced glycated hemoglobin, lower relative kidney weights and a reduced area under the curve during a glucose tolerance test, indicating improved glucose control. Fasting plasma adiponectin levels increased in the barley flour group and were not different than the lean control group. ZDF rats on the barley flour diet had lower relative epididymal fat pad weights than the obese control and a greater food efficiency ratio. The barley flour group also had reduced liver weights and a decreased concentration of liver lipids. The barley flour group had significantly higher concentrations of muscle acylcarnitines, a metabolite generated during fatty acid oxidation.
CONCLUSION: These results show that chronic consumption of β-glucans can improve glucose control and decrease fatty liver in a model of diabetes with obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229409     DOI: 10.1007/s00394-012-0478-2

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  63 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

3.  Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart.

Authors:  J Michael O'Donnell; Nathaniel M Alpert; Lawrence T White; E Douglas Lewandowski
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 4.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

5.  Whole grain consumption has a modest effect on the development of diabetes in the Goto-Kakisaki rat.

Authors:  Moonyeon Youn; A Saari Csallany; Daniel D Gallaher
Journal:  Br J Nutr       Date:  2011-06-30       Impact factor: 3.718

Review 6.  Oxidative stress, insulin signaling, and diabetes.

Authors:  Justin L Rains; Sushil K Jain
Journal:  Free Radic Biol Med       Date:  2010-12-13       Impact factor: 7.376

7.  Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.

Authors:  Morvarid Kabir; Jean-Michel Oppert; Hubert Vidal; Francoise Bruzzo; Caroline Fiquet; Pierre Wursch; Gerard Slama; Salwa W Rizkalla
Journal:  Metabolism       Date:  2002-07       Impact factor: 8.694

8.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

9.  cis-3,4-Methylene-heptanoylcarnitine: characterization and verification of the C8:1 acylcarnitine in human urine.

Authors:  Shuming Yang; Paul Minkler; Charles Hoppel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-07-28       Impact factor: 3.205

10.  Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment.

Authors:  Jelena Anastasovska; Tulika Arora; Gina J Sanchez Canon; James R C Parkinson; Kieran Touhy; Glen R Gibson; Nachiket A Nadkarni; Po-Wah So; Anthony P Goldstone; E Louise Thomas; Mohammed K Hankir; Jan Van Loo; Neena Modi; Jimmy D Bell; Gary Frost
Journal:  Obesity (Silver Spring)       Date:  2012-01-17       Impact factor: 5.002

View more
  10 in total

1.  From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health.

Authors:  William D Fiers; Irina Leonardi; Iliyan D Iliev
Journal:  Annu Rev Nutr       Date:  2020-07-17       Impact factor: 11.848

2.  Effect of barley supplementation on the fecal microbiota, caecal biochemistry, and key biomarkers of obesity and inflammation in obese db/db mice.

Authors:  Jose F Garcia-Mazcorro; David A Mills; Kevin Murphy; Giuliana Noratto
Journal:  Eur J Nutr       Date:  2017-08-16       Impact factor: 5.614

Review 3.  Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Fereidoun Azizi
Journal:  World J Diabetes       Date:  2014-06-15

4.  Effect of mushroom polysaccharides from Pleurotus eryngii on obesity and gut microbiota in mice fed a high-fat diet.

Authors:  Daiki Nakahara; Cui Nan; Koichiro Mori; Motoki Hanayama; Haruhisa Kikuchi; Shizuka Hirai; Yukari Egashira
Journal:  Eur J Nutr       Date:  2019-12-21       Impact factor: 5.614

Review 5.  Molecular Mechanism of Functional Ingredients in Barley to Combat Human Chronic Diseases.

Authors:  Yawen Zeng; Xiaoying Pu; Juan Du; Xiaomeng Yang; Xia Li; Md Siddikun Nabi Mandal; Tao Yang; Jiazhen Yang
Journal:  Oxid Med Cell Longev       Date:  2020-03-30       Impact factor: 6.543

6.  Effects of β-glucan Rich Barley Flour on Glucose and Lipid Metabolism in the Ileum, Liver, and Adipose Tissues of High-Fat Diet Induced-Obesity Model Male Mice Analyzed by DNA Microarray.

Authors:  Kento Mio; Chiemi Yamanaka; Tsubasa Matsuoka; Toshiki Kobayashi; Seiichiro Aoe
Journal:  Nutrients       Date:  2020-11-19       Impact factor: 5.717

Review 7.  β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application.

Authors:  Emma J Murphy; Emanuele Rezoagli; Ian Major; Neil J Rowan; John G Laffey
Journal:  J Fungi (Basel)       Date:  2020-12-10

8.  Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice.

Authors:  Junki Miyamoto; Keita Watanabe; Satsuki Taira; Mayu Kasubuchi; Xuan Li; Junichiro Irie; Hiroshi Itoh; Ikuo Kimura
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

9.  Effect of High β-glucan Barley on Postprandial Blood Glucose and Insulin Levels in Type 2 Diabetic Patients.

Authors:  Yukie Fuse; Mariko Higa; Naoko Miyashita; Asami Fujitani; Kaoru Yamashita; Takamasa Ichijo; Seiichiro Aoe; Takahisa Hirose
Journal:  Clin Nutr Res       Date:  2020-01-28

10.  The USDA barley core collection: genetic diversity, population structure, and potential for genome-wide association studies.

Authors:  María Muñoz-Amatriaín; Alfonso Cuesta-Marcos; Jeffrey B Endelman; Jordi Comadran; John M Bonman; Harold E Bockelman; Shiaoman Chao; Joanne Russell; Robbie Waugh; Patrick M Hayes; Gary J Muehlbauer
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.